The Walter Reed Army Institute of Research conducted a Phase 1 first-in-human trial of a Middle East respiratory syndrome coronavirus vaccine candidate that was shown to be safe, well-tolerated, and induced a robust immune response comparable to response seen in survivors of natural MERS CoV infection. Initial findings were published today in The Lancet Infectious Diseases and have prompted further trials of the vaccine co-developed by GeneOne Life Science Inc. and Inovio Pharmaceuticals.
Sleep extension increases total sleep time without decreasing overall activity levels. These data, collected by WRAIR in partnership with Washington State University scientists as part of a broader experiment to test the impact of sleep extension and subsequent sleep deprivation on health and performance, were recently published in the journal Sleep Medicine.
Three Walter Reed Army Institute of Research scientists who participated in the development of a Zika vaccine candidate have been profiled for a story on the Army’s recruiting website. The story follows Sgt. Bedh Yadav, Dr. Kayvon Modjarrad and Lt. Col. Melinda Hamer through their roles in developing, refining and testing the Zika vaccine.